Impact of Prior Cytoreductive Nephrectomy on Efficacy in Patients with Synchronous Metastatic Renal Cell Carcinoma Treated with Avelumab plus Axitinib or Sunitinib: Post Hoc Analysis from the JAVELIN Renal 101 Phase 3 Trial
Grimm, Marc-Oliver, Oya, Mototsugu, Choueiri, Toni K, Motzer, Robert J, Schmidinger, Manuela, Quinn, David I, Gravis-Mescam, Gwenaelle, Verzoni, Elena, Van den Eertwegh, Alfonsus J M, di Pietro, Alessandra, Mariani, Mariangela, Wang, Jing, Thomaidou, Despina, Albiges, Laurence
Published in European urology (01.01.2024)
Published in European urology (01.01.2024)
Get full text
Journal Article
665P Role of prior nephrectomy for synchronous metastatic renal cell carcinoma (mRCC) on efficacy in patients treated with avelumab + axitinib (A + Ax) or sunitinib (S): Results from JAVELIN Renal 101
Grimm, M-O., Oya, M., Choueiri, T.K., Schmidinger, M., Quinn, D.I., Gravis Mescam, G., Verzoni, E., Van den Eertwegh, A.J.M., di Pietro, A., Mariani, M., Wang, J., Thomaidou, D., Albiges, L.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
Feasibility and activity of everolimus in patients (pts) with advanced urothelial carcinoma (UC) pretreated with 2 lines of chemotherapy (CT) including a platinum containing regimen (PCR): The French AFINIVEST study
Theodore, Christine, Gravis Mescam, Gwenaelle, Meunier, Jérome, Guillot, Aline, Lharidon, Tifenn, Voog, Eric, Aubert, Delphine
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article